Equities

Roquefort Therapeutics PLC

ROQ:LSE

Roquefort Therapeutics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)5.60
  • Today's Change0.75 / 15.46%
  • Shares traded6.49m
  • 1 Year change-20.00%
  • Beta0.0324
Data delayed at least 20 minutes, as of Oct 31 2024 16:28 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Income statement information is not available for Roquefort Therapeutics PLC.
Gross margin--
Net profit margin--
Operating margin--
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in GBPView more

Cash flow information is not available for Roquefort Therapeutics PLC.
Cash flow per share--
Price/Cash flow per share--
Book value per share--
Tangible book value per share--
More ▼

Balance sheet in GBPView more

Roquefort Therapeutics PLC has little financial risk as the capital structure does not rely on leverage.
Current ratio--
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.